Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024)
Artiva Biotherapeutics' (ARTV) quarterly Minority Interest came in at $119.6 million in Q2 2024, up 23.64% on a QoQ basis from $96.8 million in Q4 2023.
Artiva Biotherapeutics (ARTV) Minority Interest (2023 - 2024) Analysis & Trends
Artiva Biotherapeutics (ARTV) has 2 years of Minority Interest data on file, last reported at $119.6 million in Q2 2024.
- On a quarterly basis, Minority Interest changed N/A year-over-year to $119.6 million in Q2 2024; TTM through Jun 2024 was $119.6 million, a N/A change from a year earlier, with the FY2023 full-year figure at $96.8 million, changed N/A from the prior year.
- Minority Interest for Q2 2024 stood at $119.6 million, up from $96.8 million in the prior quarter.
- Over the last five years, Minority Interest for ARTV reached as high as $119.6 million in Q2 2024 and fell as low as $96.8 million in Q4 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Artiva Biotherapeutics | 249.99 Mn | 249.99 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 119.65 Mn |
| Dec 31, 2023 | 96.77 Mn |